HydroPearl 8HP2S200Recalls & reported problems
Microvention, Inc. · Bland Beads · Class 2 · Implant
All models of HydroPearl (2)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00812636020624), received between Feb 21, 2020 and Feb 21, 2020 — classified as 1 injury.
1 other recall cover devices cleared under the same FDA submission (K150870); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Anaphylactic Shock1
- Low Blood Pressure/ Hypotension1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryFeb 21, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT CHEMOEMBOLIZATION TREATMENT WAS PERFORMED ON A VESSEL IN THE LIVER. PRIOR TO DELIVERY OF THE LIFEPEARL DEVICE, ANGIOGRAMS WITH CONTRAST MEDIA WERE TAKEN WITHOUT ANY PROBLEMS. AFTER REACHING THE TARGET VESSEL, THE LIFEPEARL LOADED WITH 50 MG DOXORUBICIN WAS MIXED WITH 8 ML NACL AND 8 ML CONTRAST MEDIA. IMMEDIATELY AFTER BEGINNING THE SLOW INJECTION, THE PATIENT FELT WARM AND HAD A "WARM HEAD." A COOL COMPRESS WAS PUT ON THE PATIENT'S HEAD AND A SMALL AMOUNT OF THE LIFEPEARL WAS INJECTED. THE PATIENT BEGAN TO MOVE AND "GET NERVOUS." HYDROPEARL WAS THEN INJECTED TO ENSURE THE EMBOLIZATION WAS COMPLETED. AT THIS TIME, THE PATIENT'S BLOOD PRESSURE AND RESPIRATION RATE DROPPED RAPIDLY AND HE BECAME UNCONSCIOUS. SOLU DECORTIN AND IV ADRENALIN WERE ADMINISTERED TO STABILIZE THE PATIENT. AFTER PREPARATION FOR INTUBATION AND CARDIAC RESUSCITATION, THE PATIENT SLOWLY BEGAN TO RECOVER. NO RESUSCITATION WAS REQUIRED. THERE WAS NO REPORTED ISSUE WITH THE PREPARATION OR DELIVERY OF THE HYDROPEARL.
Patient problems: Anaphylactic Shock; Low Blood Pressure/ Hypotension
MAUDE report 9742509 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K150870. One submission often covers many models, so check the product and lot details in each record.
- Z-0868-2024 · Dec 21, 2023 · Open, ClassifiedTERUMO HydroPearl Compressible Microspheres for Embolisation REF 8HP2S600
Other Agents, embolic, for treatment of uterine fibroids devices
- Embosphere® 00884450116715Biosphere Medical · AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS1 recall8 reports
- HydroPearl HP2S0600Microvention, Inc. · Agents, embolic, for treatment of uterine fibroids1 recall0 reports
- Embosphere® 00884450109519Biosphere Medical · AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS1 recall0 reports
- Embosphere® 00884450098561Biosphere Medical · AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS8 reports
- Embosphere® 00884450098424Biosphere Medical · AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS8 reports
- Embosphere® 00884450106051Biosphere Medical · AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS3 reports
- Embosphere® 00884450116296Biosphere Medical · AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS1 report
- Cook G09665Cook Incorporated · AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page